Growing community of inventors

Darmstadt, Germany

Boris Schmidt

Average Co-Inventor Count = 5.83

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Boris SchmidtGregor Larbig (1 patent)Boris SchmidtEva-Maria Mandelkow (1 patent)Boris SchmidtJacek Biernat (1 patent)Boris SchmidtEckhard Mandelkow (1 patent)Boris SchmidtDavid George Lloyd (1 patent)Boris SchmidtHannes Braun (1 patent)Boris SchmidtMarkus Pickhardt (1 patent)Boris SchmidtPeter-Michael Kloetzel (1 patent)Boris SchmidtSumaira Umbreen (1 patent)Boris SchmidtUlrike Kuckelkorn (1 patent)Boris SchmidtSumaira c/o Frau Brigitte Herdler Umbreen (0 patent)Boris SchmidtBoris Schmidt (2 patents)Gregor LarbigGregor Larbig (12 patents)Eva-Maria MandelkowEva-Maria Mandelkow (6 patents)Jacek BiernatJacek Biernat (6 patents)Eckhard MandelkowEckhard Mandelkow (6 patents)David George LloydDavid George Lloyd (2 patents)Hannes BraunHannes Braun (1 patent)Markus PickhardtMarkus Pickhardt (1 patent)Peter-Michael KloetzelPeter-Michael Kloetzel (1 patent)Sumaira UmbreenSumaira Umbreen (1 patent)Ulrike KuckelkornUlrike Kuckelkorn (1 patent)Sumaira c/o Frau Brigitte Herdler UmbreenSumaira c/o Frau Brigitte Herdler Umbreen (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Max-planck-gesellschaft Zur Förderung Der Wissenschaften E. V. (1 from 1,289 patents)

2. Charité – Universitätsmedizin Berlin (1 from 49 patents)

3. The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth, Near Dublin (1 from 46 patents)

4. Technische Universitat Darmstadt (1 from 36 patents)

5. Technische Universitat (1 from 5 patents)


2 patents:

1. 8835392 - Mimetic peptides and the use thereof in the form of 20S, 26S and immunoproteasome inhibitors

2. 8410152 - Thiazolhydrazides for treatment of neurodegenerative diseases

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…